5905-52-2CC(O)C(=O)[O-].CC(O)C(=O)[O-].[Fe+2]DKKCQDROTDCQOR-UHFFFAOYSA-LSee also: Ferrous cation (has active moiety) ... View More ...
5905-52-2、85993-25-5、92542-68-2DTXSID501018671Foods -> FDA Regulatory Status of Color Additives
FLAVORING AGENT OR ADJUVANT -> FDA Substance added to food
COLOR OR COLORING ADJUNCT, NUTRIENT SUPPLEMENT -> FDA Substance added to food
Soluble in water. Practically insoluble in ethanol
Slight characteristic odor; mild, sweet and ferruginous taste; on exposure to air it becomes darker and incompletely soluble; greenish-white powder or crystalline masses; soluble in water, freely sol in alkali citrates, almost insoluble in alcohol. /Trihydrate/
Greenish-white crystals or light green powder having a characteristic smell
Trihydrate: Greenish-white solid; [Merck Index] Light green solid; [MSDSonline]
MP: DECOMPOSES; 2.1 G SOL IN 100 CC WATER AT 10 °C, 8.5 G SOL IN 100 CC WATER AT 100 °C, INSOL IN ETHER /TRIHYDRATE/
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
This chemical does not meet GHS hazard criteria for 1.3% (13 of 988) of reports.
Warning
H302 (96.3%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 988 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
This chemical does not meet GHS hazard criteria for 0.5% (2 of 402) of reports.
Certification of this color additive when used for coloring ripe olives is not necessary for the protection of the public health, and therefore batches thereof are exempt from the certification pursuant to section 721(c) of the act.
Substance added directly to human food affirmed as generally recognized as safe (GRAS).
Ferrous lactate used as a nutrient and/or dietary supplement in animal drugs, feeds, and related products is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
Acute Tox. 4 (96.3%)
Acute Tox. 4 (96.8%)
Used as a food color and medication (iron deficiency anemia); [Merck Index]
Food coloring; hematinic
MEDICATION
MEDICATION (VET)
GMELIN'S IRON (8TH ED) 59, PART B, PAGE 532 (1932). PREPN OF ISOTONIC SOLUTIONS: HAMMARLUND, PHARM ACTA HELV 35, 593 (1960).
By interaction of calcium lactate with ferrous sulfate or direct action of lactic acid on iron filings. /Trihydrate/
Food additives
Food Additives -> COLOUR_RETENTION_AGENT; NUTRIENT_SUPPLEMENT -> JECFA Functional Classes
개요Ferrous lactate (iron (II) lactate, C6H10FeO6), in the trihydrate form is a greenish-white powder or crystalline mass having a characteristic odor. The levo-enantiomer occurs as the dihydrate and the racemic mixture occurs as the trihydrate. It is prepared by reacting calcium lactate or sodium lactate with ferrous sulfate or by direct reaction of lactic acid with iron filings. It is sparingly soluble inwater and practically insoluble in ethanol. A 1 in 50 solution has a pH between 5 and 6.
용도Ferrous lactate which functions to enrich and fortify. It is of neutral color and flavor, and is soluble. It is used in acid foods below a pH of 4.5, where there is less susceptibility to oxidation and conversion to the ferric form, which results in discoloration. In higher pH foods, the instability can be prevented by complexing with ligands which prevent browning discoloration. It is used in fortification of drinks and juices.
현재 필터 조건에 해당하는 반응 기록이 없습니다.
불러오는 중…
Deliquescent; affected by light; combustible /Trihydrate/
Standard molar enthalpy (heat) of formation at 298.15 deg K is -272.0 kJ/mol (crystal)
Molar enthalpy (heat) of fusion 24 kJ/mol at 1377 °C
Sugar, glycerin, & many organic hydroxy acids hinder precipitation. In neutral solution, soluble carbonates, phosphates, & oxalates produce precipitation. /Ferrous salts/
Greenish-white crystals; slight peculiar odor. Soluble in water; insoluble in alcohol. Deliquescent, affected by light. Combustible.
SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational exposure or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal, aquatic, and plant life; and conformance with environmental and public health regulations.
SRP: The scientific literature for the use of contact lenses in industry is conflicting. The benefit or detrimental effects of wearing contact lenses depend not only upon the substance, but also on factors including the form of the substance, characteristics and duration of the exposure, the uses of other eye protection equipment, and the hygiene of the lenses. However, there may be individual substances whose irritating or corrosive properties are such that the wearing of contact lenses would be harmful to the eye. In those specific cases, contact lenses should not be worn. In any event, the usual eye protection equipment should be worn even when contact lenses are in place.
All ... /iron/ preparations should be kept in child-proof bottles. /Iron preparations/
/LABORATORY ANIMALS: Subchronic or Prechronic Exposure/ Eosinophilic gastroenterocolitis with peripheral eosinophilia was induced in rats fed a diet containing 2.5% or 5.0% iron lactate for 3 months. Additional findings consistent with iron overload were also observed. Microscopically, the lesions consisted of eosinophilic infiltrations in the mucosa and submucosa along the whole length of the gastrointestinal tracts, increased surface area of the gastric mucosal propria covered with mucous cells, and increased apoptotic bodies in the gastric glandular neck of rats in the 2.5% and 5.0% groups. An increased number of intraepithelial globule leukocytes in the gastric and intestinal lamina propria was also observed in the 5.0% group. Globule leukocytes in the gastric mucosa contained obviously enlarged granules in their cytoplasm in these rats. The granules of the globule leukocytes were positive for rat mast cell protease II, suggesting the mastocyte origin of these cells. Although severe infiltration of eosinophils and globule leukocytes suggested a type-1 hypersensitivity reaction, other features such as an increasing vascular permeability were not detected. Serum IgE levels in the 5.0% and control groups were <3 ng/mL. Final body weights of male and female rats of the 5.0% group were suppressed to 70% and 90%, respectively, of those of the control rats, whereas food consumption was comparable to that of the control group. The morphologic characteristics of the gastrointestinal lesions and peripheral eosinophilia induced in rats fed iron lactate were very similar to those in some cases of eosinophilic gastroenterocolitis in humans and other animals.
/LABORATORY ANIMALS: Subchronic or Prechronic Exposure/ Osteopenia was induced in rats fed a diet containing 50,000 ppm (5%) iron lactate for 2 or 4 weeks. Blood chemistry, urinalysis, and bone histomorphometry of the proximal tibial metaphysis were performed. Urinary pyridinoline and deoxypyridinoline and the osteoclast number per bone surface were selected for the measurement of dynamic resorption. The osteoclast surface, eroded surface, and osteoblast surface increased at both ends of the exposure periods, and bone resorption and formation both increased. The bone volume, trabecular thickness, and trabecular number decreased, and the secondary spongiosa of proximal metaphysis showed a marked bone loss. However, no mineralization defect was observed. At the end of the 2-week exposure period, biomarkers of osteoclasts and osteoblasts had increased the most, and the osteoblast surface, osteoclast surface, and osteoclast number per bone surface increased with prolonged exposure. The pathological changes of the bone lesion in iron lactate-overloaded rats were similar to those in rats of the osteoporotic model, because they consisted of changes reflecting the increase of bone resorption and formation without an osteomalacic change. However, the decline of serum parathyroid hormone (PTH) levels was different from that of the osteoporosis model rat.
/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ The synergistic effects of iron overload and ethanol on the liver of mice were studied over a period of 46 weeks. The determination of several parameters (iron, calcium, magnesium, alpha-hydroxyproline, lipid peroxidation, hepatomegalic and splenomegalic indexes) showed that ferrous and ferric lactates provoke an increase of calcium in the liver, higher than that of ethanol in the control animals. The relationship between liver calcium homeostasis modification and the increase of collagen and lipid peroxidation is discussed. Histological examinations showed differences in the tissular characteristics especially when iron and ethanol were given together.
/GENOTOXICITY/ A number of ferrous and ferric salts have been tested for mutagenicity using the following organisms. Saccharomyces cerevisiae strain D-4, Salmonella typhimurium strains. TA-1535, TA-1537, and TA-1538 with and without activation. Plate tests as well as suspension tests were run with the Salmonella strains. Ferrous lactate... /was/ inactive in all the systems used.
...There is concern that the individual with metabolic defects that impair the ability to regulate iron absorption will be at risk from excessive exposure to iron, primarily as a result of acceleration of accumulation of iron in the body and an earlier onset of clinical symptoms of the disease. /Iron salts/
Basic treatment: Establish a patent airway. Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if necessary. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for shock and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with normal saline during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool. /Iron and related compounds/
Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious. Monitor cardiac rhythm and treat arrhythmias if necessary ... . Start an IV with lactated Ringer's /SRP: "To keep open", minimal flow rate/. Watch for signs of fluid overload. For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Iron and related compounds/
Maintain an open airway and assist ventilation if necessary. Treat shock caused by hemorrhagic gastrointestinitis aggressively with intravenous crystalloid fluids, and replace blood if needed. Patients are often markedly hypovolemic owing to gastrointestinal losses and third spacing of fluids into the intestinal wall and interstitial space. Treat coma, seizures, and metabolic acidosis if they occur. For seriously intoxicated victims (eg, shock, severe acidosis, and/or serum iron > 500-600 mcg/dL) administer deferoxamine. Monitor the urine for the urine for the characteristic orange or pink deferoxamine-iron complex. Therapy may be stopped when the urine returns to normal or when the serum iron level decreases to the normal range. Prolonged deferoxamine has been associated with adult respiratory distress syndrome and Yersinia sepsis.
Activated charcoal is not effective. Ipecac is not recommended, because it can aggravate iron-induced gastrointestinal irritation and interfere with whole bowel irrigation. Consider gastric lavage if product was a liquid formulation or tablets were chewed. Do-not use phosphate-containing solutions for lavage; these may result in life-threatening hypernatremia, hyperphosphatemia, and hypocalcemia. Bicarbonate and deferoxamine lavage are of doubtful efficacy. Deferoxamine lavage is not effective and may enhance iron absorption. Whole-bowel irrigation is very effective for ingested tablets and may be considered first-line treatment, especially if large numbers of tablets are visible on plain abdominal x-ray. Massive ingestions may lead to concretions or bezoars. Repeated or prolonged whole-bowel irrigation may remove tablets. Endoscopy or surgical gastrotomy is rarely required.
Hemodialysis and hemoperfusion are not effective for removing iron but may be necessary to remove iron-deferoxamine complex in patients with renal failure. Exchange transfusion is occasionally used for massive pediatric ingestions but is of questionable efficacy.
LD50 Mouse oral 137 +/- 30 mg/kg
LD50 Rabbit sc 578 mg/kg /Trihydrate/
LD50 Rabbit iv 287 mg/kg /Trihydrate/
LD50 Mouse oral 147 mg/kg
Certification of this color additive when used for coloring ripe olives is not necessary for the protection of the public health, and therefore batches thereof are exempt from the certification pursuant to section 721(c) of the act.
Substance added directly to human food affirmed as generally recognized as safe (GRAS).
Ferrous lactate used as a nutrient and/or dietary supplement in animal drugs, feeds, and related products is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
일반 설명Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
순도시험(1) 용상 : 이 품목 1g에 물 20mL를 가하여 수욕상에서 가열하여 녹일 때, 그 액은 거의 징명하여야 한다. (2) 염화물 : 이 품목 0.1g을 염화물시험법에 따라 시험할 때, 그 양은 0.01N 염산 0.2mL에 대응하는 양 이하이어야 한다. (3) 황산염 : 이 품목 0.2g을 물 5mL에 녹이고 다시 물을 가하여 10mL로 한 다음 2mL를 취하여 황산염시험법에 따라 시험할 때, 그 양은 0.01N 황산 0.4mL에 대응하는 양 이하이어야 한다. (4) 비소 : 이 품목을 비소시험법에 따라 시험할 때, 그 양은 4.0ppm 이하이어야 한다. (5) 납 : 이 품목 5.0g을 취하여 원자흡광광도법 또는 유도결합플라즈마발광광도법에 따라 시험할 때, 그 양은 1.0ppm 이하이어야 한다. (6) 카드뮴 : 이 품목 5.0g을 취하여 원자흡광광도법 또는 유도결합플라즈마발광광도법에 따라 시험할 때, 그 양은 1.0ppm 이하이어야 한다. (7) 수은 : 이 품목을 수은시험법에 따라 시험할 때, 그 양은 1.0ppm 이하이어야 한다. (8) 제이철 : 이 품목 5g을 정밀히 달아 250mL 공전삼각플라스크에 넣고 물 100mL 및 염산 10mL를 가하여 녹인다. 이 액에 요오드화칼륨 3g을 넣고 잘 흔들어 섞은 후 어두운 곳에서 5분간 방치한 다음 전분시액을 지시약으로 하여 0.1N 치오황산나트륨용액으로 적정할 때, 그 양은 0.6% 이하이어야 한다. 0.1N 치오황산나트륨용액 1mL = 5.585mg Fe(III) (9) 황산정색물 및 낙산염 : 이 품목의 분말 0.5g에 황산 1mL를 섞을 때, 곧 색을 나타내어서는 아니 되며 지방산 같은 냄새를 발생하여서는 아니 된다.
확인시험(1) 이 품목 0.5g을 450~550℃에서 1시간 강열하여 얻은 잔류물에 염산(1→2) 3mL를 가해서 가열하여 녹인 액은 확인시험법 중 제이철염의 반응을 나타낸다. (2) 이 품목은 확인시험법 중 젖산염의 반응을 나타낸다.
정량법이 품목 약 1g을 정밀히 달아 천천히 가열하여 탄화하고 질산 1mL를 가하여 액이 비산하지 않도록 주의하면서 증발건고한 다음 강열한다. 잔류물에 염산(1→2) 10mL를 가하여 불용물이 거의 없어질 때까지 끓이고 물을 가하여 20mL로 하여 여과한다. 불용물을 물로 씻고 그 씻은 액을 여액에 합쳐 물을 가하여 100mL로 한다. 그 중 25mL를 공전플라스크에 넣고 요오드칼륨 2g을 가하여 밀전하여 어두운 곳에 15분간 방치한 다음 물 100mL를 가하여 유리된 요오드를 0.1N 치오황산나트륨용액으로 적정한다(지시약 : 전분시액). 따로 같은 방법으로 공시험을 한다.0.1N 치오황산나트륨용액 1mL = 5.585mg Fe